Robotic vs. Non-Robotic Single-Site Hysterectomy: Marchand Institute’s New Meta-Analysis Provides Clarity on Surgical Outcomes
We’re thrilled to announce that Dr. Marchand’s latest study has just been published in the Journal of the Turkish-German Gynecological Association (J Turk Ger Gynecol Assoc), and it’s freely available online today!
The article, titled “Meta-analysis of changes in epithelial ovarian cancer incidence rates associated with salpingectomy: A comparison of 2022-2023 and earlier periods”, was published online on February 4, 2026. This important work from the Marchand Institute provides compelling evidence on the protective effects of salpingectomy against epithelial ovarian cancer (EOC), one of the most serious gynecologic malignancies.
Key highlights from our study include:
- A comprehensive systematic review and meta-analysis of cohort studies involving over 5.8 million women.
- Salpingectomy (particularly opportunistic procedures) was associated with a substantial 77.7% reduction in EOC incidence (risk ratio = 0.223, 95% CI: 0.182–0.274, p<0.001).
- The analysis draws on high-quality data with low risk of bias, reinforcing salpingectomy as a promising preventive strategy during gynecologic surgeries for average-risk women, with appropriate informed consent.
Congratulations to our entire research team—Greg Marchand, Daniela Gonzalez Herrera, Brooke Hamilton, McKenna Robinson, Emily Kline, Sarah Mera, Michelle Koshaba, Greenley Jephson, Nidhi Pulicherla, and Ali Azadi—on this outstanding contribution to women’s health and ovarian cancer prevention! Your rigorous analysis adds valuable insights to the growing body of evidence supporting opportunistic salpingectomy and helps guide clinical practice toward better outcomes.
In line with the journal’s open access policy, the full article is freely accessible right now—no subscription or paywall required. Dive into the complete text, including the abstract, methods, results, discussion, and references, at the following link:
Full article (HTML version): https://jtgga.org/articles/meta-analysis-of-changes-in-epithelial-ovarian-cancer-incidence-rates-associated-with-salpingectomy-a-comparison-of-20222023-and-earlier-periods/doi/jtgga.galenos.2025.2025-5-7
We encourage clinicians, researchers, and anyone interested in gynecologic oncology to read and share this timely publication from the Marchand Institute. Advances like this bring us closer to reducing the burden of ovarian cancer through proactive, evidence-based strategies.
Here’s to continued progress in women’s health! 🎉
Related posts
